Oksitetrasiklinin koyunlarda geleneksel ve uzun etkili formülasyonlarının farmakokinetiğinin karşılaştırılması

The pharmacokinetics of conventional and long-acting oxytetracycline (OTC) formulation were evaluated in sheep at a single dosage of 20 mg-$kg^{-1}$ body weight (bw). Conventional formulation was injected by intravenous (IV) route and long-acting formulation of oxytetracycline was administered by intramuscular (IM) route. Then blood samples were taken at 0.25, 0.5, 1, 2, 4, 8, 12, 24, 36, 48, 60, 72, 84 and 96 hours. Oxytetracycline analysis was performed by HPLC in plasma. The plasma drug concentration-time profile was characteristic of a two-compartment open model. Following IM administration, time to reach maximal plasma drug concentration was 2 hours and maximal plasma drug concentration was 5.13±0.31 µg/ml. After IV and IM administration of oxytetracycline, the elimination times were 1.14±1.13 and 18.92±1.86 hours, respectively. Intramuscular bioavailability was found to be 73%. Also, AUC was found to be 106.24±8.92 and 78.92±5.07 µg- $ml^{-1}$ $hours^{-1}$, respectively, IV and IM.

Coparison of the pharmacokinetics of conventional and long acting formutaions of oxytetracycline in sheep

The pharmacokinetics of conventional and long-acting oxytetracycline (OTC) formulation were evaluated in sheep at a single dosage of 20 mg-$kg^{-1}$ body weight (bw). Conventional formulation was injected by intravenous (IV) route and long-acting formulation of oxytetracycline was administered by intramuscular (IM) route. Then blood samples were taken at 0.25, 0.5, 1, 2, 4, 8, 12, 24, 36, 48, 60, 72, 84 and 96 hours. Oxytetracycline analysis was performed by HPLC in plasma. The plasma drug concentration-time profile was characteristic of a two-compartment open model. Following IM administration, time to reach maximal plasma drug concentration was 2 hours and maximal plasma drug concentration was 5.13±0.31 µg/ml. After IV and IM administration of oxytetracycline, the elimination times were 1.14±1.13 and 18.92±1.86 hours, respectively. Intramuscular bioavailability was found to be 73%. Also, AUC was found to be 106.24±8.92 and 78.92±5.07 µg- $ml^{-1}$ $hours^{-1}$, respectively, IV and IM.

___

  • 1. Nouws,J.F.M., and Vree,T.B. Effect of injection site on the bioavailability of an oxytetracycline formulation in ruminant calves. Vet. Quarterly, 1983; 5:165-170.
  • 2. Schifferli, D., Galeazzi, R.L., Nicolet, J. and Wanner, M. Pharmacokinetics of oxytetracyline and therapeutic implications in veal calves. J. Vet. Pharmacol. Therap. 19825; 247-257.
  • 3. Ziv, G. and Sulman, F.G. Analysis of pharmacokinetic properties of nine tetracycline analogues in dairy cows and ewes. Am. J. Vet. Res. 1974; 35:1197-1201.
  • 4. Moreno, L., Serrano, J.M. and Guimera. Pharmacokinetics of oxytetracycline after intramuscular administration with lidocaine in sheep, comparison with a conventional formulation. The Veterinary Sci. 1998; 65: 209-213
  • 5. Toutain, P.L. and Raynaud, J.P. Pharmacokinetics of oxytetracyline in young cattle: Comparison of conventional vs long-acting formulations. Am. J. Vet. Res. 1983; 4:1203-1209.
  • 6. Davey, L.A., Ferber, M.T. and Kaye, B. Comparison of the serum pharmacokinetics of a long-acting and conventional oxytetracycline injection. Vet. Rec. 1985; 117: 426-429.
  • 7. Sharma, J.P., Perkins,E.G. and Bevill,R.F. Reversed-phase highperformance liquid chromatographic determination of tetracyclines in urine and plasma. J. Chromatography. 1977; 134: 441-450.
  • 8. Wagner, I.G. Fundamentals of clinical pharmacokinetics. 1st Ed. Drug Intelligence Publications, Inc., Hamilton, Illinois. 1975.
  • 9. Pfizer. Ref.No.8306. Terramycine/LA: Efficacy against field cases of footrot in cattle and sheep
  • 10. Kirkwood, J.K. and Widdowson, M.A. Interspecies variation in the plasma half-life of oxytetracycline in relation to bodyweight. Res. Vet. Sci. 1990; 48: 180-183.